Lucira Health launches $153M IPO

Lucira Health launches $153M IPO

Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of $153 million. Friday’s Wall Street debut was a show of confidence, upsized from an original plan to offer...
Lucira Health Announces Pricing of Its Upsized Initial Public Offering

Lucira Health Announces Pricing of Its Upsized Initial Public Offering

EMERYVILLE, Calif.–(BUSINESS WIRE) Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the pricing of its...
Lucira Health Announces Pricing of Its Upsized Initial Public Offering

Lucira Health launches $153M IPO

Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of $153 million. Friday’s Wall Street debut was a show of confidence, upsized from an original plan to offer...
Lucira Health Announces Pricing of Its Upsized Initial Public Offering

Lucira Health Announces Pricing of Its Upsized Initial Public Offering

Feb. 5, 2021 04:27 UTC EMERYVILLE, Calif.–(BUSINESS WIRE)– Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today...
Phoenix Venture Partners LLC Raises 3rd Fund, PVP III LP

Phoenix Venture Partners LLC Raises 3rd Fund, PVP III LP

SAN MATEO, Calif., Feb. 1, 2021 /PRNewswire/ — Phoenix Venture Partners LLC (PVP) announced today that it officially closed its latest flagship venture capital fund, PVP III LP at EOY 2020. The Fund was oversubscribed and its limited partners (both returning and...